Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Anemia as a risk factor and therapeutic target in heart failure Felker GM; Adams KF Jr; Gattis WA; O'Connor CMJ Am Coll Cardiol 2004[Sep]; 44 (5): 959-66Anemia has recently been recognized as an important comorbid condition and potentially novel therapeutic target in patients with heart failure (HF). Anemia is common in HF patients, with a prevalence ranging from 4% to 55% depending on the population studied. Multiple potential mechanisms of interaction exist between anemia and the clinical syndrome of HF, including hemodilution, inflammatory activation, renal insufficiency, and malnutrition. A growing body of literature from observational databases and clinical trials suggests that anemia is an independent risk factor for adverse outcomes in patients with HF. Although preliminary data suggest that treatment of anemia may result in significant symptomatic improvement in HF, aggressive treatment of anemia may also be associated with increased risk of hypertension or thrombosis. Multiple ongoing studies will provide definitive data on the balance of risks and benefits of anemia treatment in chronic HF.|Anemia/*epidemiology/physiopathology/therapy[MESH]|Comorbidity[MESH]|Erythropoietin/pharmacology/therapeutic use[MESH]|Heart Failure/*epidemiology/physiopathology[MESH]|Heart/drug effects[MESH]|Hematocrit[MESH]|Humans[MESH]|Kidney Failure, Chronic/epidemiology/therapy[MESH]|Recombinant Proteins[MESH]|Renal Dialysis[MESH]|Risk Factors[MESH] |